Telotristat etiprate shows benefit in treating patients With carcinoid syndrome that is inadequately controlled by somatostatin analog therapy in the phase 3 TELESTAR clinical trial
Kulke, M Horsch, D Caplin, M Anthony, L Bergsland, E Oberg, K Welin, S Warner, R Lombard-Bohas, C Kunz, P
Kulke, M
Horsch, D
Caplin, M
Anthony, L
Bergsland, E
Oberg, K
Welin, S
Warner, R
Lombard-Bohas, C
Kunz, P
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2016
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Telotristat Etiprate Shows Benefit in Treating Patients With Carcinoid Syndrome That is Inadequately Controlled by Somatostatin Analog Therapy in the Phase 3 TELESTAR Clinical Trial. 2016, 45(3):478-478 Pancreas